ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
12 announcements with these filters
Promoter Daniel Dayanand Fenn bought 2,000 open-market Hannah Joseph Hospital shares, raising his stake to 0.053%. A small SAST 29(2) disclosure with no stated transaction price.
Hannah Joseph Hospital Limited received the "Winner" award for "Best Healthcare Digital Initiative" at the 5th CII WR Health Innovation Awards 2026.
Hannah Joseph Hospital Limited received the AHPI-TN Excellence Award 2026 for Best Single Hospital (above 100 beds) in the Central Zone. This industry recognition highlights its service quality.
Daniel Dayanand Fenn, a promoter of Hannah Joseph Hospital Limited, acquired 2,000 equity shares via the open market. This transaction increased the promoter group stake to 71.484%.
Hannah Joseph Hospital concluded its 15th AGM. Members approved the audited financial statements and declared a maiden final dividend of Rs. 2 per share.
Hannah Joseph Hospital was recognized as Rank 1 in the Times Health Survey – All India Critical Care Hospital Ranking 2026. The accolade enhances the hospital’s brand reputation.
Hannah Joseph Hospital Ltd announced the date and e‑voting schedule for its 15th AGM, fixing the record date on July 08 2026. Shareholders can cast votes remotely until July 14, 2026.
Hannah Joseph Hospital Ltd reported revenue from operations of ₹49.5 Cr (+33.8% YoY) and net profit of ₹6.1 Cr (+96.8% YoY) for H2 FY26.
Hannah Joseph Hospital approved FY26 audited results and recommended a 20% final dividend. The company reported annual revenue of ₹92.05 Crore with ₹11.18 Crore profit.
Hannah Joseph Hospital scheduled a board meeting for May 29, 2026. The board will consider audited financial results for the period ended March 31, 2026.
Dr. Natarajan Arunkumar, a Designated Person at Hannah Joseph Hospital Ltd, acquired 26,000 equity shares via open market purchases on the BSE. The transactions, valued at ₹0.16 Crore, increased his shareholding from 0.26% to 0.38%. Such insider buying typically reflects management's confidence in the company's long-term value.
Hannah Joseph Hospital Ltd's promoter, Dr. Moses Joseph Arunkumar, submitted an annual declaration confirming that no encumbrances were made on promoter group shares during FY 2025-26. This regulatory disclosure under SEBI SAST Regulations signifies stable promoter shareholding with no new pledges or liens created.